Delhi, Jan14: Delhi International Airport gets it’s first genome sequencing laboratory today which will be available for Covid-19 positive arriving travellers. The positive samples will be sent to the genome sequencing lab to figure out the new mutant of Covid-19 i.e. Sars-Cov-2 which have been discovered in the UK.
Today morning the inauguration of the lab will be done by Dr Vinod Paul, Niti Aayog, the chairman and national expert group on vaccine administration for Covid-19 (NEGVAC). Dr Anurag Agrawal, director, CSIR-Institute of Genomics and Integrative Biology, Ajay Singh and managing director, SpiceJet, and Avani Singh, a chief executive officer also will be there in the inauguration program.
On 23rd December 2020, the genome sequencing process started in India when 19 returnees from the UK tested positive of Covid-19. The presence of the new UK variant has already been reported by Denmark, Netherlands, Australia, Italy, Sweden, France, Spain, Switzerland, Germany, Canada, Japan, Lebanon and Singapore.
For this specific purpose, The laboratory network-- Indian Sars-CoV-2 Genomics Consortium (Insacog) was specifically created. The labs are NIMHANS, Bengaluru, CCMB, Hyderabad, NIV, Pune, IGIB, Delhi, NCDC, New Delhi, NCBG, Kolkata, NCBS, InSTEM, Bengaluru, CDFD Hyderabad, ILS Bhubaneswar, and NCCS Pune.